Galvin, Gaustad & Stein, LLC Zoetis Inc. Transaction History
Galvin, Gaustad & Stein, LLC
- $1.15 Billion
- Q3 2025
A detailed history of Galvin, Gaustad & Stein, LLC transactions in Zoetis Inc. stock. As of the latest transaction made, Galvin, Gaustad & Stein, LLC holds 88,124 shares of ZTS stock, worth $10.5 Million. This represents 1.12% of its overall portfolio holdings.
Number of Shares
88,124
Previous 68,718
28.24%
Holding current value
$10.5 Million
Previous $10.7 Million
20.32%
% of portfolio
1.12%
Previous 0.97%
Shares
3 transactions
Others Institutions Holding ZTS
# of Institutions
2,070Shares Held
426MCall Options Held
1.82MPut Options Held
1.94M-
Vanguard Group Inc Valley Forge, PA42.3MShares$5.03 Billion0.1% of portfolio
-
Black Rock Inc. New York, NY36.8MShares$4.38 Billion0.15% of portfolio
-
State Street Corp Boston, MA19.6MShares$2.33 Billion0.1% of portfolio
-
Morgan Stanley New York, NY16.9MShares$2.01 Billion0.16% of portfolio
-
State Farm Mutual Automobile Insurance CO Bloomington, IL15.9MShares$1.89 Billion1.96% of portfolio
About Zoetis Inc.
- Ticker ZTS
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 468,139,008
- Market Cap $55.6B
- Description
- Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...